Peter F. Kador
Department of Pharmaceutical Sciences
College of Pharmacy
University of Nebraska Medical Center
Omaha
United States of America
Name/email consistency: high
- Novel diabetic mouse models as tools for investigating diabetic retinopathy. Kador, P.F., Zhang, P., Makita, J., Zhang, Z., Guo, C., Randazzo, J., Kawada, H., Haider, N., Blessing, K. PLoS. ONE (2012)
- Effect of an aldose reductase inhibitor on alveolar bone loss associated with periodontitis in diabetic rats. Kador, P.F., Hamada, T., Reinhardt, R.A., Blessing, K. Postgrad. Med (2010)
- Polyol formation in cell lines of rat retinal capillary pericytes and endothelial cells (TR-rPCT and TR-iBRB). Kador, P.F., Randazzo, J., Blessing, K., Makita, J., Zhang, P., Yu, K., Hosoya, K., Terasaki, T. J. Ocul. Pharmacol. Ther (2009)
- Asteroid hyalosis: pathogenesis and prospects for prevention. Kador, P.F., Wyman, M. Eye. (Lond) (2008)
- Evaluation of the vascular targeting agent combretastatin a-4 prodrug on retinal neovascularization in the galactose-fed dog. Kador, P.F., Blessing, K., Randazzo, J., Makita, J., Wyman, M. J. Ocul. Pharmacol. Ther (2007)
- Topical aldose reductase inhibitor formulations for effective lens drug delivery in a rat model for sugar cataracts. Kador, P.F., Randazzo, J., Babb, T., Koushik, K., Takamura, Y., Zhu, W., Blessing, K., Kompella, U.B. J. Ocul. Pharmacol. Ther (2007)
- Age-dependent retinal capillary pericyte degeneration in galactose-fed dogs. Kador, P.F., Takahashi, Y., Akagi, Y., Blessing, K., Randazzo, J., Wyman, M. J. Ocul. Pharmacol. Ther (2007)
- Anticataract activity of analogs of a sorbitol dehydrogenase inhibitor. Kador, P.F., Inoue, J., Blessing, K. J. Ocul. Pharmacol. Ther (2004)
- Effect of galactose diet removal on the progression of retinal vessel changes in galactose-fed dogs. Kador, P.F., Takahashi, Y., Akagi, Y., Neuenschwander, H., Greentree, W., Lackner, P., Blessing, K., Wyman, M. Invest. Ophthalmol. Vis. Sci. (2002)